Mesoblast (ASX:MSB) - Webinar Presentation ********* 4.3K subscribers
4 views 8 Mar 2024Silviu Itescu - CEO - Mesoblast (ASX:MSB) is using its proprietary mesenchymal lineage cell technology platform to develop and commercialise innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care.
Mesoblast (ASX:MSB) - Webinar Presentation ********* 4.3K...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.010(0.89%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.19 | $1.13 | $6.618M | 5.723M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 42729 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 64034 | 16 |
View Market Depth
| Last trade - 14.49pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.14 |
Change
0.010 ( 1.57 %) |
||||
| Open | High | Low | Volume | ||
| $1.16 | $1.19 | $1.13 | 1025436 | ||
| Last updated 15.10pm 22/05/2024 ? | |||||
| MSB (ASX) Chart |